St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
Pleuropulmonary blastoma (PPB) is a rare form of lung cancer. It typically affects children under age 6.
The cause is not always known. But certain genetic changes may increase the risk of PPB. Some children with PPB have a change in the DICER1 gene or a family history of DICER1 syndrome.
The severity of PPB depends on its type. There are 4 types:
Knowing the type is important. It helps doctors choose the best treatment plan.
Treatment for PPB depends on the tumor type. It may include:
Early diagnosis and treatment can improve outcomes for children with this disease.
St. Jude offers clinical trials and cancer research studies for children, teens, and young adults with pleuropulmonary blastoma. Learn more about clinical research at St. Jude.
Study goal:
To standardize treatments for all types of pleuropulmonary blastoma and find safer, more effective ways to treat children with this rare lung cancer
Age:
Under age 6
St. Jude provides the highest quality of care for patients with pleuropulmonary blastoma:
More reasons to choose St. Jude for care include:
Patients accepted to St. Jude must have a disease we treat and must be referred by a physician or other qualified medical professional. We accept most patients based on their ability to enroll in an open clinical trial.
Call: 1-888-226-4343 (toll-free) or 901-595-4055 (local) | Fax: 901-595-4011 | Email: referralinfo@stjude.org | 24-hour pager: 1-800-349-4334
The solid tumor coordinator is dedicated to helping you seek treatment or refer a patient.
Solid Tumor Coordinator